Search clinical trials for: Bi-PAP

Total 5309 results

Cairo University

Completed

Maxillary Versus Bi-Maxillary Posterior Segments Intrusion Adult Subjects With Skeletal Open Bite

Dental Malocclusion

Egypt
Boehringer Ingelheim

Completed

A Study in Patients With Mild or Moderate Ulcerative Colitis Who Take a TNF Inhibitor. The Study Investigates Whether Bowel Inflammation Improves When Patients Take BI 655130 in Addition to Their Current Therapy

Colitis, Ulcerative

United Kingdom, Denmark, Germany, Spain, Netherlands, Norway
Boehringer Ingelheim

Completed

Long-term Assessment of Safety and Efficacy of BI 695501 in Patients With Rheumatoid Arthritis

Arthritis, Rheumatoid

United States, Spain, Korea, Republic of, Thailand, Malaysia, Poland, Russian Federation, Serbia, Bulgaria, Chile, Estonia, Germany, Hungary, Ukraine
Boehringer Ingelheim

Completed

Multiple Oral Doses of BI 207127 NA in Treatment naïve and Treatment-experienced Hepatitis C Virus (HCV)-Infected Patients

Hepatitis C, Chronic
Boehringer Ingelheim

Completed

Single Rising Dose Trial of BI 425809 for Healthy Japanese and Chinese Male Subjects

Healthy

Korea, Republic of
Boehringer Ingelheim

Completed

Pharmacokinetics and Pharmacodynamic Effect of Different Multiple Oral Doses of BI 425809

Healthy

Belgium
Boehringer Ingelheim

Completed

Safety, Tolerance, and Pharmacokinetics of Single Oral Doses of BI 201335 NA and Bioavailability in Healthy Male Subjects

Healthy
University of Arizona

Completed

Unilateral Massage as a Potential Treatment for Depression

Depression

United States
Logan College of Chiropractic

Completed

A Pilot Investigational Study: Treatment of Anxiety With Non-Needle Electro-Acupuncture

Anxiety, Mild to Moderate

United States
Boehringer Ingelheim

Withdrawn

Open Label Trial to Compare BI 207127 to Telaprevir in HCV Patients

Hepatitis C, Chronic

Australia, Spain, Sweden
State Key Laboratory of Respiratory Disease

Completed

Efficacy of Simple Continuous Positive Airway Pressure on Patients With Obstructive Sleep Apnea

Sleep Apnea, Obstructive | Continuous Positive Airway Pressure | Polysomnography

China
Boehringer Ingelheim

Completed

Assessment of the Effect of BI 201335 on the QT Interval in Healthy Female and Male Subjects

Healthy
Löwenstein Medical Technology GmbH & Co. KG

Not yet recruiting

Investigation of the Accordance Between Event Detection of prismaLINE Devices and Polysomnography Using Full Face Masks (EventLAB FF)

Sleep Apnea Syndromes

Germany
VA Office of Research and Development

Completed

Treatment of Sleep-disordered Breathing in Patients With SCI

Multiple Sclerosis | Spinal Cord Injury | Sleep-disordered Breathing | Spinal Cord Disease

United States
Abcentra

Completed

A Proof-of-Activity Study With Orticumab in Subjects With Psoriasis and Cardiometabolic Risk Factors

Coronary Artery Disease | Inflammation | Psoriasis | Cardiometabolic Syndrome

United States
Boehringer Ingelheim

Completed

BI836826 Dose Escalation in Relapsed Chronic Lymphocytic Leukaemia (CLL)

Leukemia, Lymphocytic, Chronic, B-Cell

Germany, Belgium, France
First Affiliated Hospital of Wenzhou Medical University
Shanghai Zhongshan Hospital; Sir Run Run Shaw Hospital; Wuhan Asia Heart Hospital and other collaborators

Unknown

Comparison of His Bundle Pacing and Bi-Ventricular Pacing in Heart Failure With Atrial Fibrillation

Heart Failure | Atrial Fibrillation

China
Boehringer Ingelheim

Completed

Safety and Tolerability of BI 638683 After Single Rising Oral Doses in Healthy Male Subjects

Healthy

Germany
Boehringer Ingelheim

Completed

This Study Tests Whether BI 425809 Together With Brain Training Using a Computer Improves Mental Functioning in Patients With Schizophrenia

Schizophrenia

United States, United Kingdom, Australia, Canada, France, New Zealand
Boehringer Ingelheim

Completed

Safety, Tolerability, and Pharmacokinetics of Multiple Rising Doses of BI 425809 Tablets for 12 Days to Young and Elderly Healthy Male and Female Volunteers and Comparison of Pharmacokinetics of a Single Oral Dose of BI 425809 (Morning Versus Evening)

Healthy

Germany
Japan Clinical Oncology Group
Ministry of Health, Labour and Welfare, Japan

Terminated

Study of Standard CHOP Versus Biweekly CHOP in Aggressive Non-Hodgkin's Lymphoma (JCOG9809)

Non-Hodgkin's Lymphoma

Japan
Fisher and Paykel Healthcare
University Hospital, Angers; University Hospital, Grenoble

Completed

Evaluation of APAP With SensAwake in OSA and Insomnia Patients

Insomnia | Obstructive Sleep Apnea

France
Boehringer Ingelheim

Terminated

A Study to Test BI 767551 in People With Mild to Moderate Symptoms of COVID-19

COVID-19

United States, Spain
Brigham and Women's Hospital
Beth Israel Deaconess Medical Center

Completed

Sleep Apnea Intervention for Cardiovascular Disease Reduction (BestAIR)

Obstructive Sleep Apnea

United States
Fundació Institut de Recerca de l'Hospital de la...

Recruiting

Prevalence and Clinical Implications of HPV Infection in Male IBD Patients (PAPIMALE)

HPV Infection | Oral Cavity Disease | Dysplasia Anus

Spain
University of Zurich
Swiss National Science Foundation

Completed

Breath Analysis in Obstructive Sleep Apnoea

Obstructive Sleep Apnoea (OSA)

Switzerland
Hospices Civils de Lyon

Recruiting

Impact of Body Schema Distortion on Remission and Weight Regain in Anorexia Nervosa (SCAM)

Anorexia Nervosa

France
Washington University School of Medicine

Recruiting

Ultrasound and Photoacoustic Imaging of Colon and Rectal Tumor Tissue

Rectal Cancer

United States
University of Victoria

Recruiting

Physical Activity Promotion in Children Using a Novel Smartphone Game: A Pilot Randomized Controlled Trial

Physical Activity

Canada
Hypnalgesics, LLC
Tufts University

Completed

Nonpharmacologic Reduction of Periprocedural Distress and Drug Use

Dental Anxiety | Opioid Use | Drug Use | Dental Pain

United States
University Health Network, Toronto

Completed

Pap Smear Research Study

Cervical Cancer

Canada
Boehringer Ingelheim

Completed

A Study of the Safety and Efficacy of 4 Doses of BI 1744 CL Delivered Via the Respimat in Patients With Asthma.

Asthma

Austria, Germany, Poland, Romania, Slovakia, Slovenia
Boehringer Ingelheim

Completed

Bioavailability of BI 1356 After Single Oral Administration Given as Different Tablet Formulation in Healthy Male Volunteers

Healthy
University of Waterloo
Novartis

Completed

The Effect of Xiidra on Comfort and Dryness in Symptomatic Contact Lens Wearers (COLLIE)

Dry Eye

Canada
Boehringer Ingelheim

Not yet recruiting

Brightline-3: A Study to Find Out Whether Brigimadlin in Combination With Ezabenlimab Helps People With Advanced Soft Tissue Sarcoma

Advanced Soft Tissue Sarcoma | Undifferentiated Pleomorphic Sarcoma (UPS) | Myxofibrosarcoma (MFS)
Boehringer Ingelheim

Completed

Study to Investigate the Relative Bioavailability, Influence of Pantoprazole Coadministration and Food Effect of Different Oral Formulation of BI 113608

Healthy

Germany
Boehringer Ingelheim

Completed

Effect of Treatment BI 1744 CL (5 and 10 mcg) Versus Placebo on Exercise Endurance Time During Constant Work Rate Cycle Ergometry I

Pulmonary Disease, Chronic Obstructive

Australia, Austria, Canada, France, Germany
Boehringer Ingelheim

Completed

Relative Bioavailability of Empagliflozin (BI 10773) (Final Formulation) Compared to Empagliflozin (BI 10773 XX) (Trial Formulation 2) in Healthy Male and Female Volunteers

Healthy

Germany
University of Michigan
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

SafERteens M-Coach

Alcohol Drinking | Violence

United States
Shanghai Chest Hospital

Completed

Adjunctive Right Atrial Ablation for Persistent Atrial Fibrillation With Right Atrial Enlargement

Persistent Atrial Fibrillation | Right Atrial Enlargement

China
Boehringer Ingelheim

Completed

A Study to Test Whether Different Doses of BI 690517 Alone or in Combination With Empagliflozin Improve Kidney Function in People With Chronic Kidney Disease

Kidney Disease, Chronic

United States, Spain, Korea, Republic of, Belgium, Australia, Hong Kong, India, Canada, China, Germany, Italy, Japan, Malaysia, Finland, Switzerland, Turkey, Hungary, Poland, Portugal, Philippines, Czechia, Greece, Bulgaria, Brazil, Arg... and more
Boehringer Ingelheim

Completed

Safety and Efficacy of Linagliptin (BI 1356) Plus Metformin in Type 2 Diabetes, Factorial Design

Diabetes Mellitus, Type 2

Canada, Croatia, Estonia, France, Germany, India, Lithuania, Mexico, Netherlands, Romania, Russian Federation, Sweden, Tunisia, Ukraine
Chinese University of Hong Kong

Completed

Continuous Positive Airway Pressure Use in Asthma With Moderate to Severe Obstructive Sleep Apnea Patients (OSA)

OSA

China
The University of Texas Health Science Center at...

Recruiting

Heating Pad for in Office Cystoscopy and Urodynamic Testing

Pain | Anxiety | Distress, Emotional

United States
Queen's University

Terminated

Post-extubation Boussignac CPAP System in Adults With Moderate to Severe Obstructive Sleep Apnea

Obstructive Sleep Apnea (OSA)

Canada
Philip Morris Products S.A.

Completed

Nicotine Pharmacokinetics and Pharmacodynamics, Safety and Tolerability of P3P

Pharmacokinetics

Switzerland
University of Turin, Italy
Butterfly Network

Completed

POCUS for Difficult Peripheral Access in the Emergency Department - a RCT

Emergencies | Vascular Access

Italy
Boehringer Ingelheim

Completed

BI 836826 Dose Escalation in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma (NHL)

Lymphoma, Non-Hodgkin

Korea, Republic of, Germany, France
Barbara Ann Karmanos Cancer Institute

Completed

Feasibility and Utilization of an Application-based Question Prompt List

Cancer | Financial Toxicity | Question Prompt List

United States
AbbVie

Completed

A Study to Assess Usability of Risankizumab Autoinjector Combination Product in Participants With Moderate to Severe Plaque Psoriasis

Psoriasis

United States

Search clinical trials for: Bi-PAP

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ecuador

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations